Fac Notes. 1998 Nov-Dec;10(6):6. Unique Identifier : AIDSLINE AIDS/20700004
Abstract: Two trials are being conducted by the Tulane-LSU Adult AIDS Clinical Trials Unit. ACTG 384 is for patients who have not had previous antiretroviral therapy. Study objectives address when to use protease inhibitor (PI) therapy, comparisons between different drug combinations, and long-term treatment. ACTG 398 is for people who are PI experienced. The purpose of the trial is to determine the viral suppression of Amprenavir in conjunction with other antiretroviral medication. Some of the study criteria are discussed. Contact information is provided.
Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .